An interim 18F-FDG PET/CT exam after two cycles of neoadjuvant chemotherapy was predictive of pathologic response and disease-free survival in patients with triple-negative breast cancer, an aggressive subtype of breast cancer, according to a prospective study published online Jan. 12 in the Journal of Nuclear Medicine.
The Image Gently campaign and the Society of Nuclear Medicine (SNM) have launched the “Go With the Guidelines” campaign to encourage community hospitals, academic hospitals and clinics to observe new North American Guidelines for Nuclear Medicine Radiopharmaceutical Dose in children.
In a performance evaluation, the National Electrical Manufacturers Association found the NanoPET/CT system to be of significant value in preclinical research, according to an article published in the November issue of the Journal of Nuclear Medicine.
Citing significant variations in pediatric radiopharmaceutical doses and package inserts lacking pediatric doses, the authors of an article appearing in the November issue of Radiology indicated recently approved consensus guidelines for pediatric administered radiopharmaceutical doses may help solve the problem.
Patients seeking information about nuclear medicine and molecular imaging can now access discoverMI.org, a patient-focused website launched by the Society of Nuclear Medicine (SNM).
89Zr-desferrioxamine B-7E11 displays high tumor-to-background tissue contrast in immuno-PET and can be used as a tool to monitor and quantify with high specificity tumor response in prostate-specific membrane antigen (PSMA)-positive prostate cancer, according to research published in the October issue of the Journal of Nuclear Medicine.
The Society of Nuclear Medicine Technologist Section has re-launched its Professional Development and Education Fund, which was created in 2001, and aims to support the advancement of molecular and nuclear medicine technologists through professional development that promotes clinical excellence and optimal patient outcomes.
The Society of Nuclear Medicine has announced the theme for this year’s Nuclear Medicine Week, Oct. 2-8, is “Visualizing a Brighter and Healthier Tomorrow,” and released a toolkit for nuclear and molecular imaging professionals.
Measuring bone marrow cellularity is typically done using a biopsy of the iliac crest, but a recent study published in the Journal of Nuclear Medicine indicates that MRI images may also adequately, and noninvasively, measure in vivo bone marrow cellularity.
The Society of Nuclear Medicine (SNM) has announced the recipients of the 2011-2013 SNM Wagner-Torizuka Fellowship, which is a two-year fellowship designed to provide extensive training and experience in the fields of nuclear medicine and molecular imaging for Japanese physicians in the early stages of their careers.
In 1.7 percent of patients, aneurysm was found incidentally on PET/CT, and thrombus was present in 44 percent of these cases, according to a study in the September issue of the Journal of Nuclear Medicine. The overall prognosis for any cancer may be worsened by concurrent thrombosis, according to the study authors.
Phantom and in vivo experiments have demonstrated the feasibility of simultaneous PET and 3D fluorescence optical tomography (FOT) imaging, according to research published in the August issue of the Journal of the Nuclear Medicine.
A PET-guided treatment algorithm was proven feasible, according to the results of the MUNICON II trial, published in this month’s Journal of Nuclear Medicine. However, by comparing the groups of non-responding patients in the current trial and the previous published MUNICON I trial, increased histopathologic response was observed after salvage radiochemotherapy, but the study’s primary endpoint to increase the R0 resection rate was not met.
18F-florbetaben had high sensitivity for Alzheimer’s disease (AD), clearly distinguished patients with frontotemporal lobar degeneration (FTLD) from AD and provided results comparable to those reported with 11C-Pittsburgh Compound B in a variety of neurodegenerative diseases, according to a study in the August issue of the Journal of Nuclear Medicine.
Roswell Park Cancer Institute in Buffalo, N.Y., has been named a Center of Quantitative Imaging Excellence by the National Cancer Institute (NCI).
Researchers found low fetal radiation exposures in a retrospective study assessing the effects of F-FDG PET studies performed on pregnant patients with cancer, according to findings published in the July issue of the Journal of Nuclear Medicine.
Myocardial perfusion reserve (MPR) is a more sensitive predictor for cardiac death than left ventricular ejection fraction and extent of viability, based on a study in this month’s Journal of Nuclear Medicine.
For nearly 40 years, residents have had to decide between one of two tracks for nuclear medicine training, a fragmented and outdated system that, thanks to shifts toward healthcare reform and molecular imaging, must be reconciled, according to a joint Society of Nuclear Medicine (SNM) and American College of Radiology (ACR) task force article published in the June issue of The Journal of Nuclear Medicine.
The Society of Nuclear Medicine’s (SNM) 2011 Image of the Year illustrates the ability of PET/CT scans to identify abnormal bone reaction in patients who have received spinal fixation hardware implants. Researchers selected this image from more than 1,800 studies presented over the course of four days during SNM’s 58th annual meeting in San Antonio, Texas.
Combining two imaging agents with dual isotope SPECT/CT provides diabetic patients an excellent infection screening method that has already spared a number of patients from aggressive amputation of infected feet, according to an ongoing study presented at SNM's 58th annual meeting in San Antonio, Texas.
|
RSS 
